EvidenceHunt stands out as Europe’s premier AI-powered medical information platform, assisting over 100,000 professionals in healthcare and life sciences. By offering a transformative approach to finding and utilizing medical evidence, it enhances speed and confidence in decision-making for clinicians and researchers alike.
Founded in 2024, EvidenceHunt is headquartered in The Netherlands and operates within key industries such as AI, Healthcare, and SaaS. It capitalizes on AI-driven workflows to streamline literature reviews and evidence extraction, benefiting from access to an extensive database of over 75 million articles.
The company recently secured a €1.20M seed investment on 01 February 2025, backed by prominent investors like Keen Venture Partners, Slimmer AI, DFF Ventures, Dinko Valerio, and Jeroen Tas. This financial backing underscores investor confidence in EvidenceHunt’s innovative solutions and growth potential.